These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4562114)

  • 1. Water-soluble and lipid-free fraction from BCG with adjuvant and antitumour activity.
    Hiu IJ
    Nat New Biol; 1972 Aug; 238(86):241-2. PubMed ID: 4562114
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvanticity and delayed-type hypersensitivity by Bacillus Calmette-Guérin (BCG).
    Hiu IJ; Amiel JL
    Experientia; 1972 Aug; 28(8):953-4. PubMed ID: 4561796
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimization of cell-wall skeleton derived from Mycobacterium bovis BCG Tokyo 172 (SMP-105) emulsion in delayed-type hypersensitivity and antitumor models.
    Miyauchi M; Murata M; Fukushima A; Sato T; Nakagawa M; Fujii T; Koseki N; Chiba N; Kashiwazaki Y
    Drug Discov Ther; 2012 Aug; 6(4):218-25. PubMed ID: 23006993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells.
    Miller TE; Mackaness GB; Lagrange PH
    J Natl Cancer Inst; 1973 Nov; 51(5):1669-76. PubMed ID: 4587141
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemical and biological properties of hot water extract from delipidated cells of Mycobacterium bovis strain BCG.
    Sato H; Yokosawa A; Arai H; Nagai H; Kurita K
    Tohoku J Exp Med; 1976 Sep; 120(1):75-81. PubMed ID: 785698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.
    Mathe G; Halle-Pannenko O; Florentin I; Bruley-Rosset M; Kamel M; Hiu IJ; Bourut C
    Eur J Cancer (1965); 1975 Nov; 11(11):801-7. PubMed ID: 767112
    [No Abstract]   [Full Text] [Related]  

  • 7. The chemistry and biology of a hot water extract from delipidated Mycobacterium bovis, strain BCG.
    Yokosawa A
    Sci Rep Res Inst Tohoku Univ Med; 1978 Dec; 25(3-4):65-82. PubMed ID: 379996
    [No Abstract]   [Full Text] [Related]  

  • 8. BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
    Bartlett GL; Purnell DM; Kreider JW
    Science; 1976 Jan; 191(4224):299-301. PubMed ID: 1108198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopotentiation with BCG. 3. Modulation of the response to a tumor-specific antigen.
    Hawrylko E; Mackaness GB
    J Natl Cancer Inst; 1973 Nov; 51(5):1677-82. PubMed ID: 4587142
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunotherapy of Friend disease in mice employing viable BCG vaccine.
    Larson CL; Baker RE; Ushijima RN; Baker MB; Gillespie C
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):700-2. PubMed ID: 4556666
    [No Abstract]   [Full Text] [Related]  

  • 11. Augmentation of specific macrophage-mediated cytotoxicity: correlations with agents which enhance antitumor resistance.
    Schultz RM; Papamatheakis JD; Stylos WA; Chirigos MA
    Cell Immunol; 1976 Aug; 25(2):309-16. PubMed ID: 782731
    [No Abstract]   [Full Text] [Related]  

  • 12. Potentiated immune responses after administration of aclacinomycin.
    Orbach-Arbouys S; Andrade-Mena CE; Berardet M; Mathe G
    Int Arch Allergy Appl Immunol; 1982; 68(2):117-21. PubMed ID: 7042586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunochemical study of Mycobacteria firmly bound lipids.
    Hiu IJ; Amiel JL; Nikdjou K
    Rev Eur Etud Clin Biol; 1970 Oct; 15(8):887-91. PubMed ID: 4993152
    [No Abstract]   [Full Text] [Related]  

  • 14. [A study on a hot-water extract from delipidated BCG (author's transl)].
    Sato H; Sato K; Ito M; Kumano N; Motomiya M; Konno K; Yokosawa A
    Kekkaku; 1981 Jan; 56(1):11-6. PubMed ID: 7014973
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoadjuvant treatment of primary grafted and spontaneous AKR-leukemia. I. Treatment efficiency correlated to autoimmune reactivity.
    Olsson L; Ebbesen P
    J Immunol; 1979 Mar; 122(3):772-80. PubMed ID: 376705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attempts to prevent acquired immunological insufficiencies in mice by bacillus Calmette-Guerin.
    Amiel JL; Berardet M
    Experientia; 1971 Aug; 27(8):941-3. PubMed ID: 4947883
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigens.
    Champlin R; Hunter RL
    J Immunol; 1975 Jan; 114(1 Pt 1):76-80. PubMed ID: 1089714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T; Azuma I; Aladin AA; Yamamura Y
    Gan; 1975 Dec; 66(6):705-9. PubMed ID: 817955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of immunological adjuvant component from B.C.G. cells.
    Hiu IJ; Amiel JL
    Rev Eur Etud Clin Biol; 1971; 16(1):55-8. PubMed ID: 4929110
    [No Abstract]   [Full Text] [Related]  

  • 20. Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activities.
    Bruley-Rosset M; Florentin I; Khalil AM; Mathé G
    Int Arch Allergy Appl Immunol; 1976; 51(5):594-607. PubMed ID: 786904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.